Very early researchUnknownNCT04156269What this trial is testingBCMA-CS1 Compound CAR (cCAR) T Cells for Relapsed/Refractory Multiple MyelomaWho this might be right forMultiple Myeloma iCell Gene Therapeutics 12
Early research (Phase 1)UnknownNCT05438394What this trial is testingClinical Study of Safety and Tolerability of Melphalan Hydrochloride for R/R MMWho this might be right forMultiple Myeloma Peking University People's Hospital 24
Testing effectiveness (Phase 2)Study completedNCT00006379What this trial is testingNon-Ablative Allo HSCT For Hematologic Malignancies or SAAWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more Case Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Looking for participantsNCT05372354What this trial is testingEvaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Bristol-Myers Squibb 260
Testing effectiveness (Phase 2)Study completedNCT00482495What this trial is testingBevacizumab in Treating Patients With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma and Plasma Cell Neoplasm Mayo Clinic 42
Large-scale testing (Phase 3)Study completedNCT00478777What this trial is testingA Multicenter, Single-Arm, Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple MyelomaWho this might be right forRelapsed or Refractory Multiple Myeloma Celgene Corporation 150
Early research (Phase 1)Ended earlyNCT01309412What this trial is testingCNTO 328 (Siltuximab) in Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Janssen Pharmaceutical K.K. 9
Not applicableEnded earlyNCT00726830What this trial is testingMethadone, Morphine, or Oxycodone in Treating Pain in Patients With CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more M.D. Anderson Cancer Center 1
Not applicableUnknownNCT04447573What this trial is testingImmunotherapy With BCMA CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Hebei Senlang Biotechnology Inc., Ltd. 20
Early research (Phase 1)Active Not RecruitingNCT01562405What this trial is testingSotatercept (ACE-011) With Lenalidomide or Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Massachusetts General Hospital 33
Testing effectiveness (Phase 2)Ended earlyNCT00006220What this trial is testingArsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous TherapyWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Washington University School of Medicine 5
Testing effectiveness (Phase 2)Looking for participantsNCT07681596What this trial is testingA Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple MyelomaWho this might be right forRelapsed or Refractory Multiple Myeloma AstraZeneca 101
Early research (Phase 1)Study completedNCT03275103What this trial is testingDose-Escalation Study of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)Who this might be right forMultiple Myeloma Genentech, Inc. 355
Early research (Phase 1)Study completedNCT01582295What this trial is testingXL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone DiseaseWho this might be right forMultiple Myeloma Massachusetts General Hospital 4
Testing effectiveness (Phase 2)UnknownNCT05998928What this trial is testingA Clinical Study to Evaluate the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Received Three or More Lines of TherapyWho this might be right forMultiple Myeloma Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 10
Early research (Phase 1)Study completedNCT00003107What this trial is testingInterleukin-12 in Treating Patients With Hematologic Cancers or Solid TumorsWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more Indiana University
Testing effectiveness (Phase 2)Study completedNCT01638936What this trial is testingBT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple MyelomaWho this might be right forMultiple Myeloma Biotest Pharmaceuticals Corporation 64
Testing effectiveness (Phase 2)Study completedNCT01478581What this trial is testingStudy of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed or Relapsed and Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Pharmacyclics LLC. 92
Testing effectiveness (Phase 2)Study completedNCT01701076What this trial is testingBendamustine, Lenalidomide (Revlimid®) and Dexamethasone (BRd) as 2nd-line Therapy for Patients With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Cantonal Hospital of St. Gallen 50
Early research (Phase 1)Active Not RecruitingNCT05431608What this trial is testingMCARH109 and MCARH125 in People With Multiple MyelomaWho this might be right forMultiple MyelomaRefractory Multiple MyelomaRelapse Multiple Myeloma Memorial Sloan Kettering Cancer Center 15